- Home
- WHF vs DRTS Comparison
WHF vs DRTS Comparison
Compare WHF & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHF
- DRTS
- Stock Information
- Founded
- WHF 2011
- DRTS 2015
- Country
- WHF United States
- DRTS Israel
- Employees
- WHF N/A
- DRTS N/A
- Industry
- WHF Finance Companies
- DRTS Medical/Dental Instruments
- Sector
- WHF Finance
- DRTS Health Care
- Exchange
- WHF Nasdaq
- DRTS Nasdaq
- Market Cap
- WHF 226.2M
- DRTS 211.7M
- IPO Year
- WHF 2012
- DRTS N/A
- Fundamental
- Price
- WHF $9.31
- DRTS $2.92
- Analyst Decision
- WHF Sell
- DRTS Strong Buy
- Analyst Count
- WHF 4
- DRTS 2
- Target Price
- WHF $10.83
- DRTS $8.00
- AVG Volume (30 Days)
- WHF 68.2K
- DRTS 27.2K
- Earning Date
- WHF 05-12-2025
- DRTS 05-19-2025
- Dividend Yield
- WHF 16.54%
- DRTS N/A
- EPS Growth
- WHF N/A
- DRTS N/A
- EPS
- WHF 0.47
- DRTS N/A
- Revenue
- WHF $92,817,000.00
- DRTS N/A
- Revenue This Year
- WHF N/A
- DRTS N/A
- Revenue Next Year
- WHF N/A
- DRTS N/A
- P/E Ratio
- WHF $19.86
- DRTS N/A
- Revenue Growth
- WHF N/A
- DRTS N/A
- 52 Week Low
- WHF $8.44
- DRTS $1.75
- 52 Week High
- WHF $13.44
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- WHF 40.70
- DRTS 67.20
- Support Level
- WHF $9.27
- DRTS $2.50
- Resistance Level
- WHF $9.68
- DRTS $2.67
- Average True Range (ATR)
- WHF 0.18
- DRTS 0.14
- MACD
- WHF -0.02
- DRTS 0.03
- Stochastic Oscillator
- WHF 5.88
- DRTS 91.30
About WHF WhiteHorse Finance Inc.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate attractive risk-adjusted returns for investors, primarily by originating senior secured loans to privately held small-cap companies across a broad range of industries.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range. The company derives maximum revenue from Israel.